4.8 Article

The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to bax conformational change and cell death

Journal

MOLECULAR CELL
Volume 18, Issue 6, Pages 637-650

Publisher

CELL PRESS
DOI: 10.1016/j.molcel.2005.05.010

Keywords

-

Funding

  1. Medical Research Council [MC_U132674518] Funding Source: Medline
  2. NCI NIH HHS [R37CA49152] Funding Source: Medline
  3. Breast Cancer Now [1999:98] Funding Source: Medline
  4. MRC [MC_U132674518] Funding Source: UKRI
  5. Medical Research Council [MC_U132674518] Funding Source: researchfish

Ask authors/readers for more resources

Tumor cells typically resist programmed cell death (apoptosis) induced by death receptors. Activated death receptors evoke Bax conformational change cytochrome c release, and cell death. We report that the tumor suppressor gene RASSF1A is required for death receptor-induced Bax conformational change and apoptosis. TNF alpha or TRAIL stimulation induced recruitment of RASSF1A and MAP-1 to receptor complexes and promoted complex formation between RASSF1A and the BH3-like protein MAP-1. Normally, MAP-1 is inhibited by an intramolecular interaction. RASSF1A/MAP-1 binding relieved this inhibitory interaction, resulting in MAP-1 association with Bax. Deletion of the RASSF1A gene or short hairpin silencing of either RASSF1A or MAP-1 expression blocked MAP-1/Bax interaction, Bax conformational change and mitochondrial membrane insertion, cytochrome c release, and apoptosis in response to death receptors. Our findings identify RASSF1A and MAP-1 as important components between death receptors and the apoptotic machinery and reveal a potential link between tumor suppression and death receptor signaling.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available